On 3/18/25, Sarepta Therapeutics Inc (NASDAQ: SRPT) stock suffered a major decline of -27.4%, closing at $73.54. Moreover, this decline was accompanied by exceptionally high trading volume at 1107% of normal. Relative to the market […]
REGENXBIO Inc (NASDAQ: RGNX) stock closed at $7.80 on 3/18/25 after a major increase of 11.4%. Moreover, unusually high trading volume at 173% of normal accompanied the advance. The stock has risen 29.8% during the […]
On 3/18/25, Tonix Pharmaceuticals Holding Co (NASDAQ: TNXP) stock enjoyed a major increase of 26.1%, closing at $20.53. However, this advance was accompanied by exceptionally low trading volume at 0% of normal. Relative to the […]
Elbit Systems Ltd (NASDAQ: ESLT) has reported E.P.S. of $2.02 for its fourth fiscal quarter (ending December 31) versus $0.68 for the same period a year ago — an increase of 197%. For the latest […]
DallasNews Corporation (NASDAQ: DALN) stock closed at $5.70 on 3/18/25 after a major decline of -16.3%. Moreover, trading volume in this decline was exceptionally high at 361% of normal. Relative to the market the stock […]
For its fourth fiscal quarter (ending January 31), Citi Trends Inc (NASDAQ: CTRN) has reported a -498% decline in E.P.S. from $0.43 a year ago to $-1.71 in the current quarter. E.P.S. were $-5.19 for […]
Harte Hanks Inc. (NASDAQ: HHS) stock suffered a major decline of -12.4% on 3/17/25. The shares closed at $4.36. Moreover, this decline was accompanied by exceptionally high trading volume at 364% of normal. The stock […]
Science Applications Internation (NASDAQ: SAIC) has reported E.P.S. of $2.02 for its fourth fiscal quarter (ending January 31) versus $0.75 for the same period a year ago — an increase of 169%. E.P.S. were $7.23 […]
Preformed Line Products Co (NASDAQ: PLPC). Extremely important positive changes in investment behavior have recently occurred: its longer term price trend turned up, the stock’s recent price rise disrupted its longer term downtrend, positive upside/downside […]
Lifetime Brands Inc (NASDAQ: LCUT) suffers from exceptional negative changes in fundamentals: significant quarterly sales deceleration occurred, significant quarterly earnings deceleration occurred, the consensus estimate for December, 2025 decreased significantly, and the consensus estimate for […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research